ADDRL1 Adapta L DR
Implantable Pulse Generator (IPG)
ADDRL1 Adapta L DR
Information

Device Survival Probability

ADDRL1_SEDRL1_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr at 127.0 mo                    
% Excluding Normal Battery Depletion 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0                    
% Including Normal Battery Depletion 100.0 99.9 99.9 99.8 99.7 99.5 99.3 98.9 97.8 91.5 63.9                    
#   122151 114496 104223 91227 76804 60075 43597 28405 16045 5504 572                    
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Product Characteristics

Generator Type IPG
NBD Code DDDR
Max. Delivered Energy N/A
More
Connector Style IS-1 UNI/BI
Serial Number Prefix PWE, NWE
Mass 31.3 g
Volume 13.1 cc
Waveform N/A
X-Ray ID PWB, NWE
Hide this content
IS-1 UNI/BI
Information

Estimated Longevity

Amplitude Setting 500 Lead Ω 1000 Lead Ω
Low 2.5 V (A, RV) 9.0 | 11.1* 10.0 | 12.6*
Nominal 3.5 V (A, RV) 7.3 | 8.7* 8.9 | 11.0*
High 5.0 V (A, RV) 5.4 | 6.1* 7.2 | 8.5*
Footnote

*The second longevity numbers provided apply to the N-series Adapta ADDRL1 product. The N-series products have increased longevity because of improved electronic circuitry. Click on "Other Articles" for more information on the N-series longevity. Longevity estimates based on the following device usage. Pace/Sense Mode DDD ; Atrial Pulse Width 0.4 ms; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; EGM Prestorage ON ; Upper Sensing Rate 130 ppm; Atrial Percent Paced 100 %; EGM Prestorage ON Time 1 ; Atrial Fib Percent of Time 0 % Hide this content

Information

Distribution Data

US Market Release2006-07-17
CE Approval Date2005-09-20
Registered USA Implants138221
Estimated Active USA Implants105853
Normal Battery Depletions1895
US Market Release2006-07-17
CE Approval Date2005-09-20
Estimated WW Distribution298176
Normal Battery Depletions2445
Information

Malfunctions (USA)

Therapy Function Not Compromised 13
Electrical Component 11
Electrical Interconnect 1
Possible Early Battery Depletion 1
Therapy Function Compromised 6
Electrical Component 3
Electrical Interconnect 1
Other 2
Information

Malfunctions (WW)

Therapy Function Not Compromised 37
Electrical Component 34
Electrical Interconnect 2
Possible Early Battery Depletion 1
Therapy Function Compromised 17
Electrical Component 14
Electrical Interconnect 1
Other 2
Information

EOS Indication

From the point that the ERI is set, the pacemaker will operate at ERI conditions for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Recommended Replacement (RRT)

Telemetry indication. Rate and mode change to 65 ppm and VVI respectively (VOO/65 with magnet).

Data as of November 8, 2019

www.medtronic.com/productperformance 726050